Breaking News Instant updates and real-time market news.

KTOV

Kitov Pharmaceuticals

$0.53 /

-0.0554 (-9.41%)

07:02
05/22/20
05/22
07:02
05/22/20
07:02

Kitov announces FDA acceptance of IND application for Phase 1/2 trial of NT219

Kitov Pharma announced that the U.S. Food and Drug Administration has accepted its Investigational New Drug application to conduct a Phase 1/2 clinical trial of NT219, a novel agent addressing treatment resistance in advanced cancer. The study will evaluate NT219 as monotherapy treatment of advanced solid tumors and in combination with cetuximab, an epithelial growth factor receptor blocking monoclonal antibody, for the treatment of recurrent or metastatic solid tumors and head and neck cancer or colorectal adenocarcinoma. The primary objectives of the open-label Phase 1/2 trial are to evaluate safety, assess pharmacokinetics, identify the appropriate dose to be studied in the Phase 2 portion, and establish preliminary efficacy of NT219. The Phase 1 portion of the study will encompass a dose escalation evaluation of NT219 monotherapy administered weekly in patients with refractory advanced solid tumors. Upon reaching the third dose to be given, a second cohort of patients, with either recurrent or metastatic squamous cell carcinoma of the head and neck or colorectal adenocarcinoma, will be dosed weekly with NT219, dose escalated, in combination with cetuximab. Upon completion of the mono and combination therapy Phase 1 portion of the trial and establishment of the recommended Phase 2 dose for NT219, an expansion Phase 2 component of the study will be commenced at the recommended Phase 2 dose of NT219 in combination with cetuximab in patients with recurrent/metastatic squamous cell carcinoma of the head and neck. In previously completed preclinical studies, NT219 has demonstrated compelling anti-tumor activity, as both monotherapy and in combination with cetuximab. Most recently, in an abstract published at the American Association of Cancer Research Virtual Meeting II website, positive preclinical data were presented showing that NT219 demonstrated growth inhibition, both as monotherapy, as well as in combination with cetuximab or pembrolizumab, a programmed cell death protein 1 inhibitor, in multiple patient-derived xenograft models of subjects with head and neck squamous cell carcinoma.

TODAY'S FREE FLY STORIES

Hot Stocks
Burlington Stores says sales in re-opened stores have exceeded prior year levels » 07:09
05/28/20
05/28
07:09
05/28/20
07:09
BURL

Burlington Stores

$210.31 /

+1.44 (+0.69%)

All stores were closed by…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BURL Burlington Stores
$210.31 /

+1.44 (+0.69%)

BURL Burlington Stores
$210.31 /

+1.44 (+0.69%)

05/11/20 Nomura Instinet
Burlington Stores price target raised to $190 from $170 at Nomura Instinet
03/24/20 Citi
Burlington Stores price target lowered to $205 from $260 at Citi
03/19/20 Nomura Instinet
Burlington Stores price target lowered to $170 from $252 at Nomura Instinet
03/11/20
Fly Intel: Top five analyst upgrades
BURL Burlington Stores
$210.31 /

+1.44 (+0.69%)

BURL Burlington Stores
$210.31 /

+1.44 (+0.69%)

BURL Burlington Stores
$210.31 /

+1.44 (+0.69%)

Recommendations
Micron price target raised to $70 from $60 at BofA » 07:08
05/28/20
05/28
07:08
05/28/20
07:08
MU

Micron

$49.44 /

+3.65 (+7.97%)

BofA analyst Simon Woo…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MU Micron
$49.44 /

+3.65 (+7.97%)

MU Micron
$49.44 /

+3.65 (+7.97%)

06:38 Today Morgan Stanley
Micron Q2 strength is 'reassuring,' but also understood, says Morgan Stanley
05/27/20 KeyBanc
Micron price target raised to $59 from $48 at KeyBanc
05/27/20 Wells Fargo
Micron guidance hike increase Wells' confidence in $7 per share EPS forecast
05/12/20 KeyBanc
Micron sticking with Q3 guidance, says KeyBanc
MU Micron
$49.44 /

+3.65 (+7.97%)

MU Micron
$49.44 /

+3.65 (+7.97%)

MU Micron
$49.44 /

+3.65 (+7.97%)

MU Micron
$49.44 /

+3.65 (+7.97%)

Syndicate
Yeti files to sell 6.07M shares of common stock for holders  07:08
05/28/20
05/28
07:08
05/28/20
07:08
YETI

Yeti

$33.79 /

+1.86 (+5.83%)

 
ShowHide Related Items >><<
YETI Yeti
$33.79 /

+1.86 (+5.83%)

YETI Yeti
$33.79 /

+1.86 (+5.83%)

05/05/20 Piper Sandler
Yeti price target lowered to $34 from $50 at Piper Sandler
04/28/20 BTIG
Yeti initiated with a Buy at BTIG
04/17/20 Stifel
Yeti downgraded to Hold from Buy at Stifel
04/15/20
Fly Intel: Top five analyst downgrades
YETI Yeti
$33.79 /

+1.86 (+5.83%)

YETI Yeti
$33.79 /

+1.86 (+5.83%)

YETI Yeti
$33.79 /

+1.86 (+5.83%)

YETI Yeti
$33.79 /

+1.86 (+5.83%)

Hot Stocks
WindMIL doses first patient in Phase 2 study of MILs in combo w/ nivolumab » 07:07
05/28/20
05/28
07:07
05/28/20
07:07
BMY

Bristol-Myers

$60.39 /

+0.06 (+0.10%)

WindMIL Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BMY Bristol-Myers
$60.39 /

+0.06 (+0.10%)

BMY Bristol-Myers
$60.39 /

+0.06 (+0.10%)

05/13/20 Stifel
Bluebird's ide-cel remains approvable despite FDA's 'strict stance,' says Stifel
05/13/20 Piper Sandler
Bluebird should be able to easily address RTF issues, says Piper Sandler
05/12/20 Oppenheimer
Bluebird Bio price target lowered to $111 from $122 at Oppenheimer
04/20/20 Piper Sandler
Exelixis combo approval would increase kidney cancer use, says Piper Sandler
BMY Bristol-Myers
$60.39 /

+0.06 (+0.10%)

BMY Bristol-Myers
$60.39 /

+0.06 (+0.10%)

BMY Bristol-Myers
$60.39 /

+0.06 (+0.10%)

BMY Bristol-Myers
$60.39 /

+0.06 (+0.10%)

Recommendations
Immunomedics CEO change to not impact Trodelvy launch, says H.C. Wainwright » 07:06
05/28/20
05/28
07:06
05/28/20
07:06
IMMU

Immunomedics

$34.18 /

+0.1 (+0.29%)

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
IMMU Immunomedics
$34.18 /

+0.1 (+0.29%)

IMMU Immunomedics
$34.18 /

+0.1 (+0.29%)

05:01 Today Piper Sandler
Immunomedics confident in execution despite CEO change, says Piper Sandler
05/06/20 Piper Sandler
Immunomedics well positioned to execute on Trodelvy launch, says Piper Sandler
05/05/20 Barclays
Immunomedics initiated with an Overweight, $40 target at Barclays
05/04/20 Barclays
Immunomedics initiated with an Overweight at Barclays
IMMU Immunomedics
$34.18 /

+0.1 (+0.29%)

IMMU Immunomedics
$34.18 /

+0.1 (+0.29%)

IMMU Immunomedics
$34.18 /

+0.1 (+0.29%)

IMMU Immunomedics
$34.18 /

+0.1 (+0.29%)

Hot Stocks
Dollar Tree up 2.1% after reporting Q1 results  07:05
05/28/20
05/28
07:05
05/28/20
07:05
DLTR

Dollar Tree

$87.43 /

+2.26 (+2.65%)

 
ShowHide Related Items >><<
DLTR Dollar Tree
$87.43 /

+2.26 (+2.65%)

DLTR Dollar Tree
$87.43 /

+2.26 (+2.65%)

05/26/20 Deutsche Bank
Dollar Tree price target raised to $97 from $87 at Deutsche Bank
05/18/20 Gordon Haskett
Colgate, Dollar Tree speculated as possible Peltz targets by Gordon Haskett
05/18/20
Fly Intel: Top five analyst initiations
05/18/20 Goldman Sachs
Dollar Tree initiated with a Buy at Goldman Sachs
DLTR Dollar Tree
$87.43 /

+2.26 (+2.65%)

DLTR Dollar Tree
$87.43 /

+2.26 (+2.65%)

DLTR Dollar Tree
$87.43 /

+2.26 (+2.65%)

DLTR Dollar Tree
$87.43 /

+2.26 (+2.65%)

Hot Stocks
Cerecor announces FDA clearance of IND for CERC-002 » 07:05
05/28/20
05/28
07:05
05/28/20
07:05
CERC

Cerecor

$2.73 /

+0.32 (+13.28%)

Cerecor announced that it…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CERC Cerecor
$2.73 /

+0.32 (+13.28%)

CERC Cerecor
$2.73 /

+0.32 (+13.28%)

03/13/20
Fly Intel: Top five analyst downgrades
03/13/20 Maxim
Cerecor downgraded to Hold from Buy at Maxim
01/09/20 Oppenheimer
Cerecor initiated with an Outperform at Oppenheimer
CERC Cerecor
$2.73 /

+0.32 (+13.28%)

Hot Stocks
Gan Limited announces Cordish Gaming Group as internet gambling client » 07:05
05/28/20
05/28
07:05
05/28/20
07:05
GAN

Gan Limited

$16.46 /

+0.01 (+0.06%)

Gan Limited announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GAN Gan Limited
$16.46 /

+0.01 (+0.06%)

GAN Gan Limited
$16.46 /

+0.01 (+0.06%)

05/07/20
Fly Intel: Top five analyst initiations
05/07/20 Craig-Hallum
Gan Limited initiated with a Buy at Craig-Hallum
05/07/20 B. Riley FBR
B. Riley FBR starts Gan with Buy on sports betting opportunity
05/07/20 B. Riley FBR
Gan Limited initiated with a Buy at B. Riley FBR
Earnings
Dollar Tree not issuing guidance at this time » 07:05
05/28/20
05/28
07:05
05/28/20
07:05
DLTR

Dollar Tree

$87.43 /

+2.26 (+2.65%)

Dollar Tree said in its…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DLTR Dollar Tree
$87.43 /

+2.26 (+2.65%)

DLTR Dollar Tree
$87.43 /

+2.26 (+2.65%)

05/26/20 Deutsche Bank
Dollar Tree price target raised to $97 from $87 at Deutsche Bank
05/18/20 Gordon Haskett
Colgate, Dollar Tree speculated as possible Peltz targets by Gordon Haskett
05/18/20
Fly Intel: Top five analyst initiations
05/18/20 Goldman Sachs
Dollar Tree initiated with a Buy at Goldman Sachs
DLTR Dollar Tree
$87.43 /

+2.26 (+2.65%)

DLTR Dollar Tree
$87.43 /

+2.26 (+2.65%)

DLTR Dollar Tree
$87.43 /

+2.26 (+2.65%)

DLTR Dollar Tree
$87.43 /

+2.26 (+2.65%)

Hot Stocks
Endeavour Silver restarts mining operations in Mexico » 07:05
05/28/20
05/28
07:05
05/28/20
07:05
EXK

Endeavour Silver

$1.89 /

+0.055 (+3.01%)

Endeavour Silver has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EXK Endeavour Silver
$1.89 /

+0.055 (+3.01%)

EXK Endeavour Silver
$1.89 /

+0.055 (+3.01%)

02/26/20 Noble Capital
Endeavour Silver downgraded to Market Perform from Outperform at Noble Capital
11/07/19 GMP Securities
Endeavour Silver downgraded to Hold from Buy at GMP Securities
09/23/19 Noble Capital
Endeavour Silver upgraded to Outperform from Market Perform at Noble Capital
EXK Endeavour Silver
$1.89 /

+0.055 (+3.01%)

EXK Endeavour Silver
$1.89 /

+0.055 (+3.01%)

General news
FX Update: The dollar and yen have remained weak » 07:05
05/28/20
05/28
07:05
05/28/20
07:05

FX Update: The dollar and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Earnings
Hamilton Lane reports Q4 adj. EPS 59c, consensus 49c » 07:04
05/28/20
05/28
07:04
05/28/20
07:04
HLNE

Hamilton Lane

$72.25 /

+2.48 (+3.55%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HLNE Hamilton Lane
$72.25 /

+2.48 (+3.55%)

HLNE Hamilton Lane
$72.25 /

+2.48 (+3.55%)

03/29/20 Keefe Bruyette
Hamilton Lane upgraded to Market Perform from Underperform at Keefe Bruyette
02/07/20
Fly Intel: Top five analyst initiations
02/07/20 William Blair
Hamilton Lane initiated with an Outperform at William Blair
12/19/19 Wells Fargo
Wells stays bullish on alternative asset managers into 2020, Ares top pick
HLNE Hamilton Lane
$72.25 /

+2.48 (+3.55%)

HLNE Hamilton Lane
$72.25 /

+2.48 (+3.55%)

Hot Stocks
Dollar Tree reports Q1 SSS up 7% » 07:03
05/28/20
05/28
07:03
05/28/20
07:03
DLTR

Dollar Tree

$87.43 /

+2.26 (+2.65%)

Reports Q1 Family Dollar…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DLTR Dollar Tree
$87.43 /

+2.26 (+2.65%)

DLTR Dollar Tree
$87.43 /

+2.26 (+2.65%)

05/26/20 Deutsche Bank
Dollar Tree price target raised to $97 from $87 at Deutsche Bank
05/18/20 Gordon Haskett
Colgate, Dollar Tree speculated as possible Peltz targets by Gordon Haskett
05/18/20
Fly Intel: Top five analyst initiations
05/18/20 Goldman Sachs
Dollar Tree initiated with a Buy at Goldman Sachs
DLTR Dollar Tree
$87.43 /

+2.26 (+2.65%)

DLTR Dollar Tree
$87.43 /

+2.26 (+2.65%)

DLTR Dollar Tree
$87.43 /

+2.26 (+2.65%)

DLTR Dollar Tree
$87.43 /

+2.26 (+2.65%)

Initiation
IGM Biosciences initiated with a Buy at SunTrust » 07:03
05/28/20
05/28
07:03
05/28/20
07:03
IGMS

IGM Biosciences

$63.24 /

+0.76 (+1.22%)

SunTrust analyst Asthika…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IGMS IGM Biosciences
$63.24 /

+0.76 (+1.22%)

IGMS IGM Biosciences
$63.24 /

+0.76 (+1.22%)

06:44 Today SunTrust
IGM Biosciences initiated with a Buy at SunTrust
05/08/20 Stifel
IGM Biosciences price target raised to $67 from $60 at Stifel
05/08/20 Stifel
IGM Biosciences price target raised to $67 from $60 at Stifel
05/08/20 Piper Sandler
IGM Biosciences price target raised to $81 from $53 at Piper Sandler
IGMS IGM Biosciences
$63.24 /

+0.76 (+1.22%)

Initiation
Karuna Therapeutics initiated with a Buy at H.C. Wainwright » 07:03
05/28/20
05/28
07:03
05/28/20
07:03
KRTX

Karuna Therapeutics

$87.97 /

+2.43 (+2.84%)

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KRTX Karuna Therapeutics
$87.97 /

+2.43 (+2.84%)

KRTX Karuna Therapeutics
$87.97 /

+2.43 (+2.84%)

05/08/20 Mizuho
Karuna Therapeutics price target raised to $116 from $103 at Mizuho
04/27/20 Oppenheimer
Karuna Therapeutics initiated with an Outperform at Oppenheimer
03/31/20
Fly Intel: Top five analyst initiations
03/31/20 Guggenheim
Guggenheim starts Karuna Therapeutics to Buy on schizophrenia optimism
KRTX Karuna Therapeutics
$87.97 /

+2.43 (+2.84%)

KRTX Karuna Therapeutics
$87.97 /

+2.43 (+2.84%)

KRTX Karuna Therapeutics
$87.97 /

+2.43 (+2.84%)

Hot Stocks
Canopy Rivers announces 'material reduction' in operating cash flows » 07:02
05/28/20
05/28
07:02
05/28/20
07:02
CNPOF

Canopy Rivers

$0.00 /

+ (+0.00%)

Canopy Rivers announced a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CNPOF Canopy Rivers
$0.00 /

+ (+0.00%)

Earnings
Dollar Tree reports Q1 EPS $1.04, consensus 91c » 07:02
05/28/20
05/28
07:02
05/28/20
07:02
DLTR

Dollar Tree

$87.43 /

+2.26 (+2.65%)

Reports Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DLTR Dollar Tree
$87.43 /

+2.26 (+2.65%)

DLTR Dollar Tree
$87.43 /

+2.26 (+2.65%)

05/26/20 Deutsche Bank
Dollar Tree price target raised to $97 from $87 at Deutsche Bank
05/18/20 Gordon Haskett
Colgate, Dollar Tree speculated as possible Peltz targets by Gordon Haskett
05/18/20
Fly Intel: Top five analyst initiations
05/18/20 Goldman Sachs
Dollar Tree initiated with a Buy at Goldman Sachs
DLTR Dollar Tree
$87.43 /

+2.26 (+2.65%)

DLTR Dollar Tree
$87.43 /

+2.26 (+2.65%)

DLTR Dollar Tree
$87.43 /

+2.26 (+2.65%)

DLTR Dollar Tree
$87.43 /

+2.26 (+2.65%)

Periodicals
CBS News cuts 75 staff members, NY Post reports » 07:02
05/28/20
05/28
07:02
05/28/20
07:02
VIACA

ViacomCBS

$25.98 /

+0.61 (+2.40%)

, VIAC

ViacomCBS

$22.01 /

+1.62 (+7.95%)

CBS News has cut 75 of…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VIACA ViacomCBS
$25.98 /

+0.61 (+2.40%)

VIAC ViacomCBS
$22.01 /

+1.62 (+7.95%)

VIACA ViacomCBS
$25.98 /

+0.61 (+2.40%)

04/07/20 Barrington
ViacomCBS downgraded to Market Perform from Outperform at Barrington
VIAC ViacomCBS
$22.01 /

+1.62 (+7.95%)

05/11/20
Fly Intel: Top five analyst upgrades
05/11/20 Barrington
Barrington upgrades ViacomCBS on 'significant upside' potential
05/11/20 Barrington
ViacomCBS upgraded to Outperform from Market Perform at Barrington
05/08/20 JPMorgan
ViacomCBS risk/reward attractive after positive updates, says JPMorgan
VIACA ViacomCBS
$25.98 /

+0.61 (+2.40%)

VIAC ViacomCBS
$22.01 /

+1.62 (+7.95%)

VIACA ViacomCBS
$25.98 /

+0.61 (+2.40%)

VIAC ViacomCBS
$22.01 /

+1.62 (+7.95%)

VIACA ViacomCBS
$25.98 /

+0.61 (+2.40%)

VIAC ViacomCBS
$22.01 /

+1.62 (+7.95%)

VIACA ViacomCBS
$25.98 /

+0.61 (+2.40%)

VIAC ViacomCBS
$22.01 /

+1.62 (+7.95%)

Earnings
Steven Madden reports Q1 adjusted EPS 16c, consensus 20c » 07:02
05/28/20
05/28
07:02
05/28/20
07:02
SHOO

Steven Madden

$25.78 /

+1.23 (+5.01%)

Reports Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SHOO Steven Madden
$25.78 /

+1.23 (+5.01%)

SHOO Steven Madden
$25.78 /

+1.23 (+5.01%)

05/14/20
Fly Intel: Top five analyst downgrades
05/14/20 Wells Fargo
Wells Fargo downgrades Steven Madden to Underweight on brand weakness
05/14/20 Wells Fargo
Steven Madden downgraded to Underweight from Equal Weight at Wells Fargo
05/13/20 Loop Capital
Steven Madden downgraded to Hold from Buy at Loop Capital
SHOO Steven Madden
$25.78 /

+1.23 (+5.01%)

Recommendations
Mesoblast price target raised to $21 from $14 at H.C. Wainwright » 07:01
05/28/20
05/28
07:01
05/28/20
07:01
MESO

Mesoblast

$13.10 /

+0.15 (+1.16%)

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MESO Mesoblast
$13.10 /

+0.15 (+1.16%)

MESO Mesoblast
$13.10 /

+0.15 (+1.16%)

04/09/20 H.C. Wainwright
H.C. Wainwright 'encouraged' by Mesoblast's plan to study Ryoncil in ARDS
10/22/19 Cantor Fitzgerald
Mesoblast assumed with an Overweight at Cantor Fitzgerald
09/10/19 Cantor Fitzgerald
Mesoblast partnership deal with Grunenthal a positive, says Cantor Fitzgerald
MESO Mesoblast
$13.10 /

+0.15 (+1.16%)

MESO Mesoblast
$13.10 /

+0.15 (+1.16%)

Earnings
Tempur Sealy sees Q2 revenue down approximately 30%, consensus $693.72M » 07:01
05/28/20
05/28
07:01
05/28/20
07:01
TPX

Tempur Sealy

$66.76 /

+3.425 (+5.41%)

Tempur Sealy provided an…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TPX Tempur Sealy
$66.76 /

+3.425 (+5.41%)

TPX Tempur Sealy
$66.76 /

+3.425 (+5.41%)

05/01/20 Wedbush
Tempur Sealy price target raised to $70 from $55 at Wedbush
03/30/20 SunTrust
Tempur Sealy price target lowered to $53 from $98 at SunTrust
03/30/20 Piper Sandler
Tempur Sealy a favored 'bounce-back' idea for 2021 at Piper Sandler
03/25/20 Raymond James
Tempur Sealy price target lowered to $65 from $110 at Raymond James
TPX Tempur Sealy
$66.76 /

+3.425 (+5.41%)

TPX Tempur Sealy
$66.76 /

+3.425 (+5.41%)

Recommendations
Boohoo buying rest of PLT stake at 'highly attractive price,' says Jefferies » 07:01
05/28/20
05/28
07:01
05/28/20
07:01
BHOOY

Boohoo

$0.00 /

+ (+0.00%)

After Boohoo announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BHOOY Boohoo
$0.00 /

+ (+0.00%)

05/15/20 Jefferies
Boohoo price target raised to 460 GBp from 395 GBp at Jefferies
04/24/20 RBC Capital
Boohoo price target raised to 260 GBp from 220 GBp at RBC Capital
02/11/20 Barclays
Boohoo upgraded to Overweight from Equal Weight at Barclays
Downgrade
Heico downgraded to Hold from Buy at SunTrust » 07:00
05/28/20
05/28
07:00
05/28/20
07:00
HEI

Heico

$105.24 /

+5.545 (+5.56%)

SunTrust analyst Michael…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HEI Heico
$105.24 /

+5.545 (+5.56%)

HEI Heico
$105.24 /

+5.545 (+5.56%)

06:04 Today SunTrust
Heico downgraded to Hold from Buy at SunTrust
05/18/20 Canaccord
Heico downgraded to Hold at Canaccord
05/18/20 Canaccord
Heico downgraded to Hold from Buy at Canaccord
03/31/20 Jefferies
Heico downgraded to Hold from Buy at Jefferies
HEI Heico
$105.24 /

+5.545 (+5.56%)

HEI Heico
$105.24 /

+5.545 (+5.56%)

HEI Heico
$105.24 /

+5.545 (+5.56%)

Hot Stocks
Protalix announces submission of BLA to FDA for pegunigalsidase alfa » 06:59
05/28/20
05/28
06:59
05/28/20
06:59
PLX

Protalix

$3.40 /

+0.08 (+2.41%)

Protalix BioTherapeutics,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PLX Protalix
$3.40 /

+0.08 (+2.41%)

Recommendations
CollPlant price target raised to $13 from $11 at H.C. Wainwright » 06:59
05/28/20
05/28
06:59
05/28/20
06:59
CLGN

CollPlant

$10.07 /

-0.08 (-0.79%)

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CLGN CollPlant
$10.07 /

-0.08 (-0.79%)

CLGN CollPlant
$10.07 /

-0.08 (-0.79%)

04/03/20 H.C. Wainwright
CollPlant price target raised to $11 from $7 at H.C. Wainwright
CLGN CollPlant
$10.07 /

-0.08 (-0.79%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.